Concepedia

Publication | Open Access

A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma

63

Citations

32

References

2023

Year

Abstract

Combination epacadostat and pembrolizumab was well tolerated and showed limited antitumor activity in sarcoma. Correlative analyses suggested that inadequate IDO1 inhibition was achieved.

References

YearCitations

Page 1